Indian equity markets ended Monday’s session sharply lower, with benchmark indices breaking below key psychological support levels amid heightened investor caution. The Nifty 50 fell 360.25 points, or 1.56%, to close at 22,780.25.

From a technical perspective, immediate support for the Nifty is seen in the 22,650–22,700 zone, while a break below this range could extend the correction in the near term, according to Rupak De, Senior Technical Analyst at LKP Securities.

Against this backdrop, shares of Tata Group, ITC, IRFC, NCC, Zydus Lifesciences, JSW Energy, and several other companies are likely to remain in focus on Tuesday following a series of corporate developments.

Tata Trusts, which holds a 66% stake in Tata Sons, has proposed the merger of Tata Electronics Systems Solutions Private Ltd (TESS) and Tata Consulting Engineers (TCE) with Tata Sons.

The proposal is part of a strategic reorganisation aimed at taking Tata Sons outside the regulatory framework applicable to non-banking financial companies (NBFCs) and core investment companies (CICs).

ITC

ITC has acquired a further 13,445 equity shares of Sproutlife Foods Private Limited through a secondary purchase.

Following the acquisition, ITC now holds 100% of the share capital of Sproutlife, making it a wholly owned subsidiary of the company with effect from September 28, 2026.

Indian Railway Finance Corporation (IRFC) has signed a Rs 4,200 crore term loan agreement with Damodar Valley Corporation (DVC) to finance renewable energy projects across Jharkhand and West Bengal.

ALSO READ: AI trade enters a new phase: Why DBS favours AI adopters over capex-heavy players

NCC

NCC Ltd has received a Rs 1,076.71 crore order, excluding GST, from the Rural Water Supply and Sanitation Department, Visakhapatnam, Government of Andhra Pradesh.

Zydus Lifesciences said an inspection by the US Food and Drug Administration (USFDA) at its manufacturing facility at SEZ II, Ahmedabad, has concluded with one observation.

Clean Max Enviro Energy Solutions

Clean Max Enviro Energy Solutions Ltd has raised Rs 2,500 crore through green non-convertible debentures (NCDs) on a private placement basis.

Seventy Second Investment Co is likely to sell 4.50 crore shares, representing a 3.35% equity stake in New Delhi-based highway assets operator Cube Highways Trust, through a block deal, according to reports.

JSW Energy said its Finance Committee, at a meeting held on September 28, 2026, approved the allotment of 50,000 unsecured, listed, rated, taxable and redeemable non-convertible debentures.

The NCDs have a face value of Rs 1 lakh each, taking the total issue size to Rs 500 crore.

The approval follows the company’s earlier decision to raise up to Rs 3,000 crore through, among other instruments, the issuance of rated and listed NCDs on a private placement basis.

Health and hygiene products maker Eureka Forbes Ltd has received a show-cause notice from the Uttar Pradesh Goods and Services Tax authority proposing a demand of Rs 273.40 crore for the financial year 2022-23.

Sudarshan Chemical Industries Ltd has entered into a Rs 150.76 crore share purchase agreement to acquire a 15.89% stake in Sudarshan Colorants India Ltd.

Power Mech Projects Ltd has secured a Rs 279.20 crore order from Telangana Power Generation Corporation Limited for operation and maintenance work at the Yadadri Thermal Power Station.

Pidilite Industries has partnered with South Korea-based Hwaseung Chemical to bring its footwear adhesive technology to Indian manufacturers.

Vikram Solar Ltd has secured a 400 MW module supply order from a leading EPC company in India for a portfolio of decentralised solar projects across multiple locations in Maharashtra.

Swaraj Suiting said its board has approved the issuance of up to 35 lakh equity shares on a preferential basis at an issue price of Rs 335 per share.

The proposed issue comprises a face value of Rs 10 per share and a premium of Rs 325 per share, aggregating up to Rs 117.25 crore. The issue is proposed to be made to non-promoters/identified persons, subject to shareholder and applicable regulatory approvals.

The board has also approved the issuance of up to 17 lakh warrants, convertible into an equal number of equity shares, at an issue price of Rs 335 per warrant. The proposed warrant issue will aggregate up to Rs 56.95 crore and is also subject to the requisite approvals.

Indoco Remedies Ltd said its wholly owned subsidiary, Warren Lifesciences Private Limited, was incorporated on September 26, 2026, under the provisions of the Companies Act, 2013.

Disclosure: This article has been written by Kumar Gaurav, who is not a Sebi-registered Research Analyst or an Investment Adviser. Gaurav and their ‘relative(s)’ (as defined under Section 2(77) of the Companies Act, 2013) do not hold any financial interest in the companies mentioned in this article as of the date of publication. The views/recommendations mentioned in this article, wherever applicable, are those of the respective Sebi-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They should not be construed as the views or recommendations of The Economic Times Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment. Brokerage disclaimers here